MedPath

Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting

Not Applicable
Completed
Conditions
Colorectal Cancer
Registration Number
NCT04711473
Lead Sponsor
Abramson Cancer Center at Penn Medicine
Brief Summary

This is a 3-arm randomized trial aimed at increasing rates of participation in colorectal cancer (CRC) screening by outreach to patients' homes using choice architecture informed by behavioral science principles.

Detailed Description

The investigators will evaluate the effectiveness of mailed outreach with choice between colonoscopy and FIT, and FIT alone, as compared to colonoscopy alone in increasing CRC screening rates.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
800
Inclusion Criteria
  1. At least 1 visit with CHDC in the past 2 years
  2. Not up to date on CRC screening (no evidence of colonoscopy in the last 10 years, sigmoidoscopy in the last 5 years, or stool testing in the past 12 months)
Exclusion Criteria
  1. History of CRC or polyps
  2. Significant family history of CRC
  3. History of Inflammatory Bowel Disease or Ulcerative Colitis
  4. History of colectomy
  5. History of metastatic cancer
  6. Current use of Medication Assisted Therapy (MAT)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Colorectal Cancer Screening Completion6 months from initial outreach

Screening completion rate in arm 2 (Choice) to arm 1 (Colonoscopy only) and arm 3 (FIT only) separately.

Secondary Outcome Measures
NameTimeMethod
Choice of Colorectal Cancer Screening Test6 months from initial outreach

The proportion of patients choosing either FIT or Colonoscopy in study arm 2 (Choice)

Trial Locations

Locations (1)

Community Health and Dental Care

🇺🇸

Pottstown, Pennsylvania, United States

Community Health and Dental Care
🇺🇸Pottstown, Pennsylvania, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.